Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen. The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Date de début
2024-05-27
Liebermeisterstrasse 25
72076
Liebermeisterstrasse, 72076, Tübingen, Baden Wuerttemberg, Deutschland
Postuler via
Tübingen
Im Geschäftsbereich des Ministeriums für Soziales, Gesundheit und Integration
sindbei Gesundheits- und Versorgungsämtern in den Landratsämtern zum
nächstmöglichen Zeitpunkt unbefristete und befristete Vollzeit- und
Teilzeitstellen für
Ärztinnen/Ärzte (w/m/d)
zu besetzen.
Ihre Aufgaben:
Eine vielfältige und verantwortungsvolle Tätigkeit im gesundheits- und
versorgungsärztlichen Dienst des Landes. Mitwirkung an den Zukunftsthemen im
Öffentlichen Gesundheitswesen: Public Health und Sozialmedizin. In den meisten
Gesundheitsämtern wird überdies die Teilnahme am infektiologischen Dienst
erwartet.
Bei den folgenden Landratsämtern sind Stellen in den benannten
Aufgabenbereichen zu besetzen:
- Tübingen, Kennziffer 402-AS10, psychiatrische Begutachtungen durch
Fachärztinnen, Fachärzte (w/m/d) für Psychiatrie und Psychotherapie,
hier finden Sie Informationen zum Landkreis Tübingen, fachliche Fragen
richten Sie bitte an Frau Dr. Walter-Frank, Tel. 07071 207-3301, Fragen zum
Bewerbungsverfahren richten Sie bitte an Frau Hesse-Dahlheimer, Tel.: 0711
123-3752
Ihr Profil:
Sie sind entscheidungsfreudige approbierte Ärztinnen und Ärzte mit möglichst
24-monatiger Tätigkeit in einem Gebiet der unmittelbaren Patientenversorgung.
Zudem besitzen Sie eine hohe analytische Kompetenz, arbeiten effizient, sind
lösungsorientiert und kommunizieren souverän sowie wertschätzend.
Wir weisen darauf hin, dass für Personen, die in Einrichtungen des
Öffentlichen Gesundheitsdienstes tätig werden sollen, vor Einstellung eine
Nachweispflichthinsichtlich einer Immunisierung gegen Masern besteht. Bei
Nichtvorlage eines geeigneten Nachweises ist eine Einstellung im Öffentlichen
Gesundheitsdienst ausgeschlossen.
Weitere Informationen
Schwerbehinderte Bewerberinnen und Bewerber werden bei entsprechender Eignung
bevorzugt berücksichtigt.
Unser Angebot:
- eine Einstellung auf der Grundlage des TV-L (Ärztinnen und Ärzte sind
mindestens nach Entgeltgruppe 14 eingruppiert)
- Vereinbarkeit von Familie und Beruf durch individuelle Arbeitsmodelle, ggf.
anteilig in Telearbeit
- aktive Unterstützung beim Ausbau Ihrer fachlichen und sozialen Kompetenzen
- vielfältige und umfangreiche Fort- und Weiterbildungsangebote ggf. bis zur
Anerkennung als Fachärztin/Facharzt für Öffentliches Gesundheitswesen
- Ihre Mobilität unterstützen wir mit einem Zuschuss zum Job Ticket BW
- Betriebliche Altersvorsorge für Tarifbeschäftigte
Bewerbungen mit aussagekräftigen Unterlagen bitte bis zum 9. Mai 2025 über
unserOnline-Bewerbungsportal.
Bewerbungen per Post oder E-Mail können leider nicht berücksichtigt werden.
Mit Ihrer Bewerbung stimmen Sie der Verarbeitung Ihrer personenbezogenen Daten
nach den Vorgaben der Datenschutzgrundverordnung und des
Landesdatenschutzgesetzes zu
Tübingen
Im Auftrag einer führenden Gesundheitseinrichtung suchen wir zum nächstmöglichen Zeitpunkt einen Facharzt m/w/d Allgemein- und Viszeralchirurgie. Das Akutkrankenhaus zeichnet sich durch seine Spezialisierung in den Bereichen Kardiologie, Allgemein- und Viszeralchirurgie sowie orthopädische Chirurgie aus. Mit hochmoderner Ausstattung und einem interdisziplinären Ansatz sichert die Klinik eine umfassende und patientenzentrierte Versorgung.
Alle weiteren Details zur Stelle und zum Arbeitgeber erhalten Sie in einem persönlichen Gespräch – Diskretion und Vertraulichkeit sind selbstverständlich.
Ihre Aufgaben
- Fachliche Betreuung der ambulanten und stationären Patient*innen
- Organisation und Durchführung operativer Eingriffe
- Durchführung oder Anordnung von diagnostischen und therapeutischen Maßnahmen
- Übernahme von administrativen Aufgaben
- Anleitung und Ausbildung der Assistenzärzt*innen
- Ausbau und Weiterentwicklung der Abteilung
- Zusammenarbeit mit kooperierenden Fachdisziplinen
- Teilnahme am Dienstsystem der Fachabteilung
Ihr Profil
- Deutsche Approbation
- Sprachniveau Deutsch von mindestens C1
- Facharztweiterbildung für Allgemein- oder Viszeralchirurgie
- Idealerweise Berufserfahrung in der laparoskopischen und Adipositaschirurgie
- Großes Engagement, Verantwortungsbewusstsein
- Eigeninitiative, Teamfähigkeit
- Freude und Bereitschaft an der interdisziplinären Zusammenarbeit
Freuen Sie sich auf
- Strukturierte Einarbeitung
- Weiterentwicklung Ihrer speziellen chirurgischen Befähigung
- Attraktive Fort- und Weiterbildungsangebote
- Online-Bibliothek
- Regelmäßige Fort- und Weiterbildungsmöglichkeiten
- Vergütung nach TV Ärzte / VKA (https://www.medicaltopjobs.de/de/blog/ID1400269-tarife-und-gehalt-arzt-2023-2024)
- Betriebliche Altersvorsorge
- Krankenzusatzversicherung
- Corporate -Benefits
- Mitarbeiterparkplatz
- Bike-Leasing
- Zuschuss zum Deutschlandticket
- Betriebliches Gesundheitsmamagent
- PME Familienservice
- Leben und arbeiten in einer attraktiven Region
Job-ID: 2773119 (https://medicaltopjobs.de/de/arzt-job/ID2773119-facharzt-allgemein-viszeralchirurgie-baden-wuerttemberg)
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.
Tübingen
Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance
This research project starts in October 2024 and is implemented in the RTG2816 ( https://www.rtg2816.com/ ). A scholarship will be given for 12 month, a minimum of 8 months full-time in the laboratory is required. The project focuses on understanding the role of Girdin and Daple in melanoma progression and resistance towards targeted therapies. The doctoral researcher will determine expression patterns of Girdin and Daple in melanoma patient biopsies by immunofluorescence. Furthermore, he/she will work on the identified signaling pathways and transcription factors involved in the regulation of Girdin and Daple expression and to characterize the role of identified splice variants in melanoma progression and therapy resistance in established 2D and 3D skin models. Our goal is to develop strategies to interfere with the development of therapy resistance in melanoma patients. The MD student will closely work together with a PhD student in the lab and other students in the RTG2816. The MD student is integrated in the curriculum of the RTG2816, see website. He/she will do an experimental work in the lab, mainly doing cell culture, RNA and protein analysis, Immunofluorescnce and others. The MD student will on a regular basis present the data in the RTG seminars. The prerequisite for an application is an existing medical study (Medizinstudium) only in Tübingen.
The MD student should be familiar with cell culture wok and if possible other methods such as immunohistology/fluorescence, PCR, western blot. The student should be able to present the work in english. The MD student should study medicine in Tübingen. The project starts in October 2024. The MD student should take at least one semester off fom the study to work completely in the lab for at least 8 months full-time. A stipend will be given to the MD student for 1 year. The MD student has to attend the RTG seminars and lectures for 2 years.